Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1650 of 1958 entries
View as:

Performance Status During Treatment With Pemetrexed in Patients With NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00540241 Org: User:
Start: 09/30/07 End: 03/31/10 Due: 03/31/11

A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.

Phase: N/A Priority: Normal
NCT ID: NCT00734604 Org: User:
Start: 08/31/08 End: 09/30/09 Due: 09/30/10

Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00623233 Org: User:
Start: 03/31/08 End: 01/31/11 Due: 01/31/12

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

Phase: N/A Priority: Normal
NCT ID: NCT00316225 Org: User:
Start: 12/31/06 End: 03/31/09 Due: 03/31/10

Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00050206 Org: User:
Start: 11/30/02 End: 05/31/05 Due: 05/31/06

Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT00073411 Org: User:
Start: 11/30/03 End: 05/31/05 Due: 05/31/06

A Study of LY3848575 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05727072 Org: User:
Start: 02/10/23 End: 02/19/24 Due: 02/19/25

Safety Study in Outpatient Japanese Children With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00485628 Org: User:
Start: 04/30/03 End: 10/31/03 Due: 10/31/04

A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04840901 Org: User:
Start: 06/02/21 End: 02/11/22 Due: 02/11/23

Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)

Phase: N/A Priority: Normal
NCT ID: NCT01394952 Org: User:
Start: 07/22/11 End: 08/21/18 Due: 08/21/19

A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01859078 Org: User:
Start: 05/31/13 End: 08/31/13 Due: 08/31/14

A Study on the Effect of 2 Pen Devices on HbA1c

Phase: N/A Priority: Normal
NCT ID: NCT00985712 Org: User:
Start: 10/31/09 End: 07/31/11 Due: 07/31/12

Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00112346 Org: User:
Start: 01/31/05 End: 12/31/06 Due: 12/31/07

A Study of LY3526318 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03977974 Org: User:
Start: 06/21/19 End: 03/05/20 Due: 03/05/21

Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00520481 Org: User:
Start: 08/31/07 End: 08/31/13 Due: 08/31/14

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT05929079 Org: User:
Start: 07/11/23 End: 05/31/26 Due: 05/31/27

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Phase: N/A Priority: Normal
NCT ID: NCT00547573 Org: User:
Start: 04/30/03 End: 12/31/03 Due: 12/31/04

A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01821703 Org: User:
Start: 05/31/13 End: 09/30/13 Due: 09/30/14

A Study of LY2623091 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02300259 Org: User:
Start: 11/30/14 End: 04/30/15 Due: 04/30/16

A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01913314 Org: User:
Start: 08/31/13 End: 10/31/13 Due: 10/31/14

A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03338023 Org: User:
Start: 03/23/18 End: 03/05/20 Due: 03/05/21

A Study in Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01130532 Org: User:
Start: 08/31/10 End: 01/31/12 Due: 01/31/13

A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00102219 Org: User:
Start: 10/31/04 End: 10/31/07 Due: 10/31/08

The Forteo Alendronate Comparator Trial

Phase: N/A Priority: Normal
NCT ID: NCT02416271 Org: User:
Start: 04/30/01 End: 05/31/03 Due: 05/31/04

Safety Study of LY3041658 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02148627 Org: User:
Start: 06/16/14 End: 02/11/17 Due: 02/11/18